Key points are not available for this paper at this time.
Synergy scores obtained from LSCC cell lines treated with co-treatment with NCB-0846 and cisplatin/etoposide. Cell viability was evaluated at 48h post-treatment.
Nguyen et al. (Thu,) studied this question.